Literature DB >> 8061449

Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weight.

T S Desser1, D L Rubin, H H Muller, F Qing, S Khodor, G Zanazzi, S W Young, D L Ladd, J A Wellons, K E Kellar.   

Abstract

Macromolecular contrast media offer potential advantages over freely diffusible agents in magnetic resonance (MR) imaging outside the central nervous system. To identify an optimum molecular weight for macromolecular contrast media, the authors studied a novel macromolecular contrast agent, gadolinium diethylenetriaminepentaacetic acid polyethylene glycol (DTPA-PEG), synthesized in seven polymer (average) molecular weights ranging from 10 to 83 kd. Twenty-eight rabbits bearing V2 carcinoma in thighs underwent T1-weighted spin-echo imaging before injection and 5-60 minutes and 24 hours after injection of the Gd-DTPA-PEG polymers or Gd-DTPA at a gadolinium dose of 0.1 mmol/kg. Tumor region-of-interest measurements were obtained at each time point to determine contrast enhancement dynamics. Blood-pool enhancement dynamics were observed for the Gd-DTPA-PEG polymers larger than 20 kd. Polymers smaller than 20 kd displayed dynamics similar to those of the freely diffusible agent Gd-DTPA. Above the 20 kd threshold, tumor enhancement was more rapid for smaller polymers. The authors conclude that the 21.9-kd Gd-DTPA-PEG polymer is best suited for clinical MR imaging.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061449     DOI: 10.1002/jmri.1880040337

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  8 in total

Review 1.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice.

Authors:  Xueming Wu; Yi Feng; Eun-Kee Jeong; Lyska Emerson; Zheng-Rong Lu
Journal:  Pharm Res       Date:  2009-07-14       Impact factor: 4.200

3.  Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents.

Authors:  Sang Young Jeong; Hyo Jeong Kim; Byung-Kook Kwak; Ha-Young Lee; Hasoo Seong; Byung Cheol Shin; Soon Hong Yuk; Sung-Joo Hwang; Sun Hang Cho
Journal:  Nanoscale Res Lett       Date:  2010-09-02       Impact factor: 4.703

Review 4.  Gadolinium-based contrast agents for magnetic resonance cancer imaging.

Authors:  Zhuxian Zhou; Zheng-Rong Lu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-10-09

5.  Macromolecular Imaging Agents Containing Lanthanides: Can Conceptual Promise Lead to Clinical Potential?

Authors:  Joshua Bryson; Jeffrey W Reineke; Theresa M Reineke
Journal:  Macromolecules       Date:  2012-11-13       Impact factor: 5.985

6.  Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.

Authors:  Yi Feng; Eun-Kee Jeong; Aaron M Mohs; Lyska Emerson; Zheng-Rong Lu
Journal:  Magn Reson Med       Date:  2008-12       Impact factor: 4.668

7.  Macromolecular Crowding May Significantly Affect the Performance of an MRI Contrast Agent: A 1H NMR Spectroscopy, Microimaging, and Fast-Field-Cycling NMR Relaxometry Study.

Authors:  Ren-Hao Cheng; Jie-Min Chen; Yu-Wen Chen; Honghao Cai; Xiaohong Cui; Dennis W Hwang; Zhong Chen; Shangwu Ding
Journal:  ChemistryOpen       Date:  2018-03-13       Impact factor: 2.911

8.  Near-Infrared Fluorescence Imaging of Breast Cancer and Axillary Lymph Nodes After Intravenous Injection of Free Indocyanine Green.

Authors:  Pierre Bourgeois; Isabelle Veys; Danielle Noterman; Filip De Neubourg; Marie Chintinne; Sophie Vankerckhove; Jean-Marie Nogaret
Journal:  Front Oncol       Date:  2021-03-09       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.